Asherman's syndrome overview: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu)) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Asherman's syndrome}} | {{Asherman's syndrome}} | ||
'''Editor(s)-in-Chief:''' | '''Editor(s)-in-Chief:''' {{CMG}}; [[User:Csinfor|Canan S Fornusek, Ph.D.]]; '''Associate Editor-In-Chief:''' {{skhan}} | ||
==Overview== | ==Overview== |
Revision as of 19:31, 6 July 2022
Asherman's syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Asherman's syndrome overview On the Web |
American Roentgen Ray Society Images of Asherman's syndrome overview |
Risk calculators and risk factors for Asherman's syndrome overview |
Editor(s)-in-Chief: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Canan S Fornusek, Ph.D.; Associate Editor-In-Chief: Saud Khan M.D.
Overview
Asherman's syndrome, also called "uterine synechiae" or intrauterine adhesions, presents a condition characterized by the presence of scars within the uterine cavity.
An artificial form of Asherman's syndrome can be surgically induced by endometrial ablation in women with excessive uterine bleeding, in lieu of hysterectomy.